Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort

Allavena, C; Flandre, P; Pugliese, P; Valantin, MA; Izopet, J; Garraffo, R; Poizot, I; Cabie, A; Yazdanpanah, Y; Cuzin, L; Duvivier, C; Katlama, C; Dellamonica, P

doi:10.1186/1758-2652-11-S1-P26

Journal of the International AIDS Society

Article metrics
Last updated: Fri, 19 Apr 2024 10:10:28 Z

Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort

Access & Citations

872

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.